Date published: 2026-2-19

1-800-457-3801

SCBT Portrait Logo
Seach Input

3-Amino-4-deoxy-4-imino Rifamycin S (CAS 62041-01-4)

0.0(0)
Write a reviewAsk a question

Alternate Names:
3-Amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxorifamycin; 3-Amino-4-iminorifamycin S; 3-Amino-1,4-dideoxy-1,4-dihydro-4-imino-1-oxorifamycin;
Application:
3-Amino-4-deoxy-4-imino Rifamycin S is a Rifamycin (R508200) derivative
CAS Number:
62041-01-4
Molecular Weight:
709.78
Molecular Formula:
C37H47N3O11
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

3-Amino-4-deoxy-4-imino Rifamycin S is an analog of rifamycin, distinguished by its structural modification which significantly influences its role in research, particularly in the study of bacterial RNA synthesis inhibition. This chemical specifically targets bacterial DNA-dependent RNA polymerase, thereby obstructing the transcription process, which is a vital step in bacterial gene expression and replication. The mechanism of action of 3-Amino-4-deoxy-4-imino Rifamycin S involves binding to the beta subunit of RNA polymerase, leading to a blockade of the RNA synthesis pathway. This unique interaction is crucial for studies focused on the transcriptional machinery of bacteria, especially in understanding how modifications in antibiotic structure can impact their efficacy and specificity. In research, this compound is used to investigate the dynamics of transcription inhibition and to explore potential strategies for overcoming antibiotic resistance. It provides a valuable tool for dissecting the mechanisms by which bacteria develop resistance to rifamycin drugs and for designing inhibitors that are less susceptible to resistance mechanisms. Studies involving 3-Amino-4-deoxy-4-imino Rifamycin S contribute to a deeper understanding of microbial physiology and the development of novel antibacterial agents.


3-Amino-4-deoxy-4-imino Rifamycin S (CAS 62041-01-4) References

  1. Design, Synthesis, and Characterization of TNP-2198, a Dual-Targeted Rifamycin-Nitroimidazole Conjugate with Potent Activity against Microaerophilic and Anaerobic Bacterial Pathogens.  |  Ma, Z., et al. 2022. J Med Chem. 65: 4481-4495. PMID: 35175750
  2. Structure-activity relationships of actively FhuE transported rifabutin derivatives with potent activity against Acinetobacter baumannii.  |  Maingot, M., et al. 2023. Eur J Med Chem. 252: 115257. PMID: 36948128
  3. Bifunctional antibiotic hybrids: A review of clinical candidates.  |  Koh, AJJ., et al. 2023. Front Pharmacol. 14: 1158152. PMID: 37397488

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

3-Amino-4-deoxy-4-imino Rifamycin S, 2.5 mg

sc-391658
2.5 mg
$360.00